Clinical Trial Update: Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies [Phase 2]

View source ↗

Summary

An update indicating that participants from Pfizer-sponsored Palbociclib Phase 2 studies may continue participation; the trial remains active but is not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer, Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING